Author:
Croos Robert,Thirumalai Srinivasa,Hassan Sabit,Davis Jane Da Roza
Abstract
Abstract
Background
Acute angle-closure glaucoma is a rare complication in patients receiving anti-depressant treatment. In the following case, we report the development of acute angle closure glaucoma in a patient who overdosed on Citalopram, an antidepressant, and discuss the possible etiological mechanisms for the condition.
Case presentation
We report a 54 year old, Caucasian lady, with depression and alcohol dependence syndrome, who developed acute angle-closure glaucoma after an overdose of Citalopram, along with alcohol. She was treated with medications and had bilateral Yag laser iridotomies to correct the glaucoma and has made complete recovery. In this case, the underlying cause for glaucoma appears to be related to the ingestion of Citalopram.
Conclusion
The patho-physiological basis for acute angle closure glaucoma in relation to antidepressant medications remains unclear. The authors suggest Citalopram may have a direct action on the Iris or Ciliary body muscle through serotonergic or anti-cholinergic mechanisms or both. This case highlights the importance of the awareness of the underlying risks, which may predispose an individual to develop acute angle-closure glaucoma, and reminds the clinicians the significance of history taking and examination of the eye before and after starting anti-depressants. This area needs to be further researched.
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference21 articles.
1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshelman S, Wittchen H, Kendler KS: Lifetime and 12 month prevalence of DSM-3R psychiatric disorders in the united states. Archives of General Psychiatry. 1994, 51: 8-19.
2. Lonquist J, Sutonen H, Syvalahti E, Appleberg B, Koskinen T, Maninikko T, Mehtones OP, Narala M, Shiro S, Auvinen J: Antidepressant efficacy and quality of life in Depression: A double blind study with moclobomide and Fluoxetine. Acta Psychiatrica Scandinavia. 1994, 89 (6): 363-9.
3. Stokes PE: Fluoxetine: A five-year review. clinical therapeutics. 1993, 15 (2): 216-43.
4. Nemeroff CB: Paroxetine: An overview of the efficacy and safety of a new selective reuptake inhibitor in the treatment of depression. Journal of clinical Psychopharmacology. 1993, 13 (suppl 2): 10S-17S.
5. Birley M, Moret C: Neurological mechanisms involved in antidepressant therapies. Clin Neuropharmacol. 1993, 16: 387-400.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献